Agile Therapeutics | AGRX - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Agile Therapeutics

Agile Therapeutics reported $-6878000 in Operating Profit for its fiscal quarter ending in December of 2022.


Operating Profit Change
Adma Biologics ADMA:US USD 39.59M 45.65M
Bayer BAYN:GR EUR 2.97B 1.54B
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
J&J JNJ:US USD -737000000 4.94B
Merck & Co MRK:US USD 3.72B 286M
Pacira PCRX:US USD -20017000 10.12M
Pfizer PFE:US USD 6.79B 1.62B
TherapeuticsMD TXMD:US USD -2667000 69.68M